BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24085852)

  • 41. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen.
    Wigelsworth DJ; Krantz BA; Christensen KA; Lacy DB; Juris SJ; Collier RJ
    J Biol Chem; 2004 May; 279(22):23349-56. PubMed ID: 15044490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anthrax toxin requires ZDHHC5-mediated palmitoylation of its surface-processing host enzymes.
    Sergeeva OA; van der Goot FG
    Proc Natl Acad Sci U S A; 2019 Jan; 116(4):1279-1288. PubMed ID: 30610172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calpain-mediated proteolysis of talin regulates adhesion dynamics.
    Franco SJ; Rodgers MA; Perrin BJ; Han J; Bennin DA; Critchley DR; Huttenlocher A
    Nat Cell Biol; 2004 Oct; 6(10):977-83. PubMed ID: 15448700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Roles of Anthrax Toxin Receptor 2 in Anthrax Toxin Membrane Insertion and Pore Formation.
    Sun J; Jacquez P
    Toxins (Basel); 2016 Jan; 8(2):34. PubMed ID: 26805886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Membrane translocation by anthrax toxin.
    Collier RJ
    Mol Aspects Med; 2009 Dec; 30(6):413-22. PubMed ID: 19563824
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells.
    Singh Y; Klimpel KR; Goel S; Swain PK; Leppla SH
    Infect Immun; 1999 Apr; 67(4):1853-9. PubMed ID: 10085027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LRP5 and LRP6 are not required for protective antigen-mediated internalization or lethality of anthrax lethal toxin.
    Young JJ; Bromberg-White JL; Zylstra C; Church JT; Boguslawski E; Resau JH; Williams BO; Duesbery NS
    PLoS Pathog; 2007 Mar; 3(3):e27. PubMed ID: 17335347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improving the anti-toxin abilities of the CMG2-Fc fusion protein with the aid of computational design.
    Xi Y; Wu X; Gao L; Shao Y; Peng H; Chen H; Chen H; Hu X; Yue J
    PLoS One; 2014; 9(8):e104674. PubMed ID: 25101992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proteome analysis of mouse macrophages treated with anthrax lethal toxin.
    Chandra H; Gupta PK; Sharma K; Mattoo AR; Garg SK; Gade WN; Sirdeshmukh R; Maithal K; Singh Y
    Biochim Biophys Acta; 2005 Mar; 1747(2):151-9. PubMed ID: 15698949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New aspects of the infection mechanisms of Bacillus anthracis.
    Zakowska D; Bartoszcze M; Niemcewicz M; Bielawska-Drózd A; Kocik J
    Ann Agric Environ Med; 2012; 19(4):613-8. PubMed ID: 23311776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Ins and Outs of Anthrax Toxin.
    Friebe S; van der Goot FG; Bürgi J
    Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26978402
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anthrax Edema and Lethal Toxins Differentially Target Human Lung and Blood Phagocytes.
    Patel VI; Booth JL; Dozmorov M; Brown BR; Metcalf JP
    Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32698436
    [No Abstract]   [Full Text] [Related]  

  • 53. Cytoskeleton as an emerging target of anthrax toxins.
    Trescos Y; Tournier JN
    Toxins (Basel); 2012 Feb; 4(2):83-97. PubMed ID: 22474568
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anthrax toxin receptor 2-dependent lethal toxin killing in vivo.
    Scobie HM; Wigelsworth DJ; Marlett JM; Thomas D; Rainey GJ; Lacy DB; Manchester M; Collier RJ; Young JA
    PLoS Pathog; 2006 Oct; 2(10):e111. PubMed ID: 17054395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of the Antigen Capture Pathway in the Induction of a Neutralizing Antibody Response to Anthrax Protective Antigen.
    Verma A; Ngundi MM; Price GA; Takeda K; Yu J; Burns DL
    mBio; 2018 Feb; 9(1):. PubMed ID: 29487236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anthrax toxin triggers the activation of src-like kinases to mediate its own uptake.
    Abrami L; Kunz B; van der Goot FG
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1420-4. PubMed ID: 20080640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calpain- and talin-dependent control of microvascular pericyte contractility and cellular stiffness.
    Kotecki M; Zeiger AS; Van Vliet KJ; Herman IM
    Microvasc Res; 2010 Dec; 80(3):339-48. PubMed ID: 20709086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum protease cleavage of Bacillus anthracis protective antigen.
    Ezzell JW; Abshire TG
    J Gen Microbiol; 1992 Mar; 138(3):543-9. PubMed ID: 1593265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.
    Zai X; Zhang J; Liu J; Liu J; Li L; Yin Y; Fu L; Xu J; Chen W
    Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26927174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monitoring anthrax toxin receptor dissociation from the protective antigen by NMR.
    Rajapaksha M; Eichler JF; Hajduch J; Anderson DE; Kirk KL; Bann JG
    Protein Sci; 2009 Jan; 18(1):17-23. PubMed ID: 19177347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.